Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Bullboard Posts
Comment by Chainsawwon Nov 18, 2010 9:25am
229 Views
Post# 17723341

RE: RE: NOV 17 TRADES

RE: RE: NOV 17 TRADESThe last one i posted is just the trades for the day.  what you can tell is who the main players are and which way they trade the most.  Stick with the most powerful group and that appears to be the buyers right now.  The stock is moving up and ready for a breakout.  The bears are losing power and when their selling subsides then we move up.
the broker summary for the day or any period shows THE NET BUYERS AND NET SELLERS AND THE AVERAGE PRICES.  IF YOU LOOK BACK ON THE ONE I POSTED FOR MAY TO THE PRESENT YOU CAN SEE WHO TO FOLLOW AS FAR AS THE BUYERS.  I THINK THIS IS THE INTERINVEST FOLKS BUYING AND SOON WE WILL GET A NICE MOVE IN THE PRICE
Bullboard Posts